Harrow (HROW) EPS (Diluted) (2016 - 2026)
Powered by 
Analysis
Harrow (HROW) EPS (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | -3.06 |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 7.27 |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | -0.46 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.46 |
| Mar 31, 2026 | -0.74 |
| Dec 31, 2025 | 0.28 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.38 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.27 |
| Sep 30, 2021 | -0.31 |